Results 121 to 130 of about 4,569 (190)

Brazilian profile of Radium-223 in metastatic prostate cancer: a multicentric, retrospective study. [PDF]

EJNMMI Rep
Souza S, Ribeiro F, Brito A, Minekawa T, Lopes F, Matedi S, Fockink R, Anjos D, Gomes G, Silva L, Camacho M, Santos A, Araújo W, Teixeira A, Martins R, Sanches A, Hanaoka N, Tavares R, Villela-Pedras F, Mourato F, Torricelli C, Alves T, Tavares M, Lima M, Moraes A, Sasse A, Almeida P, Etchebehere E.   +27 more
europepmc   +1 more source

Outcomes and Factors Associated with Completion of Radium-223 Therapy. [PDF]

Nucl Med Mol Imaging, 2022
Liu RF, Juwara L, Ferrario C, Probst SM.
europepmc   +1 more source

Impact of radium-223 on bone imaging and biochemical markers with and without bone-modifying agents in bone-metastatic castration-resistant prostate cancer: results from the kyucog-1901 study. [PDF]

Eur J Nucl Med Mol Imaging
Shiota M, Enokida H, Murakami Y, Kamoto T, Igawa T, Masumori N, Uemura H, Mitsunari K, Sumiyoshi T, Uemura H, Higashijima K, Tokunaga S, Isoda T, Ishigami K, Eto M.   +14 more
europepmc   +1 more source

Recurrent Extraneural Metastatic Medulloblastoma in an Adult Presenting With a Superscan and Treated With Radium-223. [PDF]

Cureus, 2023
Mou B, Cruz-Lim EM.
europepmc   +1 more source

Prognostic factors for overall survival in patients with metastatic castration-resistant prostate cancer treated with radium-223: a meta-analysis of real-world evidence. [PDF]

Front Oncol
Song B, Shao H, He Y, Zhu X, Qin P.
europepmc   +1 more source

Sequencing of Radium-223 and Lutetium-177 Vipivotide Tetraxetan: Maximizing the Benefit of Systemic Targeted Radiation Therapy in Metastatic Castration-Resistant Prostate Cancer. [PDF]

Oncol Ther
Mehr S, Hauke R.
europepmc   +1 more source

A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases. [PDF]

Future Oncol
Tombal B, Saad F, Gallardo E, Soares A, Loriot Y, McDermott R, Briers E, Lagström M, Coens C, Poncet C, Fournier B, Gillessen S.   +11 more
europepmc   +1 more source

Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer. [PDF]

Cancers (Basel)
Zang PD, Da Silva DM, Liu ZX, Kandukuri S, Tsao-Wei D, D'Souza A, Kast WM, Pal SK, Kefauver C, Juanqueira M, Yang L, Quinn DI, Dorff TB.   +12 more
europepmc   +1 more source

ATM inhibition increases the anti-tumor efficacy of radium-223 (Ra-223) against prostate cancer bone metastasis in preclinical models. [PDF]

JBMR Plus
Lefley DV, Jones CG, Zhou J, Bryant HE, Collis SJ, Down JM, Brown JE, Ottewell PD.   +7 more
europepmc   +1 more source

Investigation of the safety of Radium-223 chloride in combination with external beam radiotherapy for bone metastases of prostate cancer. [PDF]

J Radiat Res
Makino S, Miyazawa K, Katsuoka Y, Ooe T, Aikawa K, Segawa A, Kobayashi H.   +6 more
europepmc   +1 more source